Protocol Ledger

NCT07001800 · Phase II/III · RECRUITING

Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study

Interventional Phase II/III clinical trial protocol NCT07001800 sponsored by Kardigan in Cardiovascular and Thrombosis, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2025-06-27 Enrollment: 1,276 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07001800
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)1,276 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07001800
Protocol FieldVerified Registry Value
NCT IdentifierNCT07001800
Consolidated Lead SponsorKardigan
Therapeutic Condition CohortCardiovascular and Thrombosis
Clinical Trial PhasePhase II/III
Overall Recruitment StatusRECRUITING
Registered Enrollment1,276 participants (ESTIMATED)
Registered Start Date2025-06-27
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Cardiovascular and Thrombosis Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI